Bupivacaine liposome and Insulin Glargine (U-100) Vials
Determining the interaction of Bupivacaine liposome and Insulin Glargine (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupivacaine liposome
Brand name: Exparel
Synonyms: Bupivacaine (Liposomal)
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupivacaine liposome-Insulin Glargine (U-300) Pens
- Bupivacaine liposome-Insulin glargine and lixisenatide
- Bupivacaine liposome-Insulin glargine and lixisenatide Subcutaneous
- Bupivacaine liposome-Insulin glargine, recombinant Subcutaneous
- Bupivacaine liposome-Insulin glulisine
- Bupivacaine liposome-Insulin Glulisine (Cartridges and Pens)
- Insulin Glargine (U-100) Vials-Bupivacaine liposome Injection
- Insulin Glargine (U-100) Vials-Bupivacaine Spinal
- Insulin Glargine (U-100) Vials-Buprenex
- Insulin Glargine (U-100) Vials-Buprenex injection - Buprenex
- Insulin Glargine (U-100) Vials-Buprenorphine
- Insulin Glargine (U-100) Vials-Buprenorphine and Naloxone